aluates Reports

$ 0.0

Automative

Global Arthritis Monoclonal Antibodies Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-36V5777

Global Arthritis Monoclonal Antibodies Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Arthritis Monoclonal Antibodies Market Research Report 2025

Code: QYRE-Auto-36V5777

Report

June 2025

Pages:74

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

F Hoffmann La Roche Ltd

Novartis

Johnson & Johnson (Janssen)

Pfizer Inc

Mylan NV

Genentech Inc

GSK

Astrazeneca plc

Arthritis Monoclonal Antibodies Market

The global market for Arthritis Monoclonal Antibodies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases

North American market for Arthritis Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Arthritis Monoclonal Antibodies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Arthritis Monoclonal Antibodies in Rheumatoid Arthritis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Arthritis Monoclonal Antibodies include AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK, AstraZeneca PLC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Arthritis Monoclonal Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arthritis Monoclonal Antibodies.

The Arthritis Monoclonal Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Arthritis Monoclonal Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Arthritis Monoclonal Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Arthritis Monoclonal Antibodies Market Report

Report Metric	Details
Report Name	Arthritis Monoclonal Antibodies Market
Segment by Type	Remicade Humira Enbrel Rituxan Orencia Actemra Simponi Cimzia
Segment by Application	Rheumatoid Arthritis Osteoarthritis Psoriatic Arthritis Ankylosing Spondylitis Fibromyalgia Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK, AstraZeneca PLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Arthritis Monoclonal Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Arthritis Monoclonal Antibodies Market report?

Ans: The main players in the Arthritis Monoclonal Antibodies Market are AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK, AstraZeneca PLC

What are the Application segmentation covered in the Arthritis Monoclonal Antibodies Market report?

Ans: The Applications covered in the Arthritis Monoclonal Antibodies Market report are Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Others

What are the Type segmentation covered in the Arthritis Monoclonal Antibodies Market report?

Ans: The Types covered in the Arthritis Monoclonal Antibodies Market report are Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Remicade

1.2.3 Humira

1.2.4 Enbrel

1.2.5 Rituxan

1.2.6 Orencia

1.2.7 Actemra

1.2.8 Simponi

1.2.9 Cimzia

1.3 Market by Application

1.3.1 Global Arthritis Monoclonal Antibodies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Rheumatoid Arthritis

1.3.3 Osteoarthritis

1.3.4 Psoriatic Arthritis

1.3.5 Ankylosing Spondylitis

1.3.6 Fibromyalgia

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Arthritis Monoclonal Antibodies Market Perspective (2020-2031)

2.2 Global Arthritis Monoclonal Antibodies Growth Trends by Region

2.2.1 Global Arthritis Monoclonal Antibodies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Arthritis Monoclonal Antibodies Historic Market Size by Region (2020-2025)

2.2.3 Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2026-2031)

2.3 Arthritis Monoclonal Antibodies Market Dynamics

2.3.1 Arthritis Monoclonal Antibodies Industry Trends

2.3.2 Arthritis Monoclonal Antibodies Market Drivers

2.3.3 Arthritis Monoclonal Antibodies Market Challenges

2.3.4 Arthritis Monoclonal Antibodies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue

3.1.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue (2020-2025)

3.1.2 Global Arthritis Monoclonal Antibodies Revenue Market Share by Players (2020-2025)

3.2 Global Arthritis Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Arthritis Monoclonal Antibodies Revenue

3.4 Global Arthritis Monoclonal Antibodies Market Concentration Ratio

3.4.1 Global Arthritis Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Arthritis Monoclonal Antibodies Revenue in 2024

3.5 Global Key Players of Arthritis Monoclonal Antibodies Head office and Area Served

3.6 Global Key Players of Arthritis Monoclonal Antibodies, Product and Application

3.7 Global Key Players of Arthritis Monoclonal Antibodies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Arthritis Monoclonal Antibodies Breakdown Data by Type

4.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Type (2020-2025)

4.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2026-2031)

5 Arthritis Monoclonal Antibodies Breakdown Data by Application

5.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Application (2020-2025)

5.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Arthritis Monoclonal Antibodies Market Size (2020-2031)

6.2 North America Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)

6.4 North America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Arthritis Monoclonal Antibodies Market Size (2020-2031)

7.2 Europe Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)

7.4 Europe Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size (2020-2031)

8.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2020-2025)

8.4 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Arthritis Monoclonal Antibodies Market Size (2020-2031)

9.2 Latin America Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)

9.4 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size (2020-2031)

10.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2020-2025)

10.4 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie Inc

11.1.1 AbbVie Inc Company Details

11.1.2 AbbVie Inc Business Overview

11.1.3 AbbVie Inc Arthritis Monoclonal Antibodies Introduction

11.1.4 AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.1.5 AbbVie Inc Recent Development

11.2 F. Hoffmann-La Roche Ltd

11.2.1 F. Hoffmann-La Roche Ltd Company Details

11.2.2 F. Hoffmann-La Roche Ltd Business Overview

11.2.3 F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Introduction

11.2.4 F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.2.5 F. Hoffmann-La Roche Ltd Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Arthritis Monoclonal Antibodies Introduction

11.3.4 Novartis Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Johnson & Johnson(Janssen)

11.4.1 Johnson & Johnson(Janssen) Company Details

11.4.2 Johnson & Johnson(Janssen) Business Overview

11.4.3 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Introduction

11.4.4 Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.4.5 Johnson & Johnson(Janssen) Recent Development

11.5 Pfizer Inc

11.5.1 Pfizer Inc Company Details

11.5.2 Pfizer Inc Business Overview

11.5.3 Pfizer Inc Arthritis Monoclonal Antibodies Introduction

11.5.4 Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.5.5 Pfizer Inc Recent Development

11.6 Mylan

11.6.1 Mylan Company Details

11.6.2 Mylan Business Overview

11.6.3 Mylan Arthritis Monoclonal Antibodies Introduction

11.6.4 Mylan Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.6.5 Mylan Recent Development

11.7 Genentech

11.7.1 Genentech Company Details

11.7.2 Genentech Business Overview

11.7.3 Genentech Arthritis Monoclonal Antibodies Introduction

11.7.4 Genentech Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.7.5 Genentech Recent Development

11.8 GSK

11.8.1 GSK Company Details

11.8.2 GSK Business Overview

11.8.3 GSK Arthritis Monoclonal Antibodies Introduction

11.8.4 GSK Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.8.5 GSK Recent Development

11.9 AstraZeneca PLC

11.9.1 AstraZeneca PLC Company Details

11.9.2 AstraZeneca PLC Business Overview

11.9.3 AstraZeneca PLC Arthritis Monoclonal Antibodies Introduction

11.9.4 AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2020-2025)

11.9.5 AstraZeneca PLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

F Hoffmann La Roche Ltd

Novartis

Johnson & Johnson (Janssen)

Pfizer Inc

Mylan NV

Genentech Inc

GSK

Astrazeneca plc

List of Tables

Table 1. Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Remicade

Table 3. Key Players of Humira

Table 4. Key Players of Enbrel

Table 5. Key Players of Rituxan

Table 6. Key Players of Orencia

Table 7. Key Players of Actemra

Table 8. Key Players of Simponi

Table 9. Global Arthritis Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Arthritis Monoclonal Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Arthritis Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Arthritis Monoclonal Antibodies Market Share by Region (2020-2025)

Table 13. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Arthritis Monoclonal Antibodies Market Share by Region (2026-2031)

Table 15. Arthritis Monoclonal Antibodies Market Trends

Table 16. Arthritis Monoclonal Antibodies Market Drivers

Table 17. Arthritis Monoclonal Antibodies Market Challenges

Table 18. Arthritis Monoclonal Antibodies Market Restraints

Table 19. Global Arthritis Monoclonal Antibodies Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Arthritis Monoclonal Antibodies Market Share by Players (2020-2025)

Table 21. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Monoclonal Antibodies as of 2024)

Table 22. Ranking of Global Top Arthritis Monoclonal Antibodies Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Arthritis Monoclonal Antibodies Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Arthritis Monoclonal Antibodies, Headquarters and Area Served

Table 25. Global Key Players of Arthritis Monoclonal Antibodies, Product and Application

Table 26. Global Key Players of Arthritis Monoclonal Antibodies, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Arthritis Monoclonal Antibodies Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2020-2025)

Table 30. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2026-2031)

Table 32. Global Arthritis Monoclonal Antibodies Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2020-2025)

Table 34. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2026-2031)

Table 36. North America Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Arthritis Monoclonal Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2026-2031) & (US$ Million)

Table 51. AbbVie Inc Company Details

Table 52. AbbVie Inc Business Overview

Table 53. AbbVie Inc Arthritis Monoclonal Antibodies Product

Table 54. AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 55. AbbVie Inc Recent Development

Table 56. F. Hoffmann-La Roche Ltd Company Details

Table 57. F. Hoffmann-La Roche Ltd Business Overview

Table 58. F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Product

Table 59. F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 60. F. Hoffmann-La Roche Ltd Recent Development

Table 61. Novartis Company Details

Table 62. Novartis Business Overview

Table 63. Novartis Arthritis Monoclonal Antibodies Product

Table 64. Novartis Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 65. Novartis Recent Development

Table 66. Johnson & Johnson(Janssen) Company Details

Table 67. Johnson & Johnson(Janssen) Business Overview

Table 68. Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Product

Table 69. Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 70. Johnson & Johnson(Janssen) Recent Development

Table 71. Pfizer Inc Company Details

Table 72. Pfizer Inc Business Overview

Table 73. Pfizer Inc Arthritis Monoclonal Antibodies Product

Table 74. Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 75. Pfizer Inc Recent Development

Table 76. Mylan Company Details

Table 77. Mylan Business Overview

Table 78. Mylan Arthritis Monoclonal Antibodies Product

Table 79. Mylan Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 80. Mylan Recent Development

Table 81. Genentech Company Details

Table 82. Genentech Business Overview

Table 83. Genentech Arthritis Monoclonal Antibodies Product

Table 84. Genentech Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 85. Genentech Recent Development

Table 86. GSK Company Details

Table 87. GSK Business Overview

Table 88. GSK Arthritis Monoclonal Antibodies Product

Table 89. GSK Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 90. GSK Recent Development

Table 91. AstraZeneca PLC Company Details

Table 92. AstraZeneca PLC Business Overview

Table 93. AstraZeneca PLC Arthritis Monoclonal Antibodies Product

Table 94. AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2020-2025) & (US$ Million)

Table 95. AstraZeneca PLC Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Arthritis Monoclonal Antibodies Picture

Figure 2. Global Arthritis Monoclonal Antibodies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Arthritis Monoclonal Antibodies Market Share by Type: 2024 VS 2031

Figure 4. Remicade Features

Figure 5. Humira Features

Figure 6. Enbrel Features

Figure 7. Rituxan Features

Figure 8. Orencia Features

Figure 9. Actemra Features

Figure 10. Simponi Features

Figure 11. Cimzia Features

Figure 12. Global Arthritis Monoclonal Antibodies Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Arthritis Monoclonal Antibodies Market Share by Application: 2024 VS 2031

Figure 14. Rheumatoid Arthritis Case Studies

Figure 15. Osteoarthritis Case Studies

Figure 16. Psoriatic Arthritis Case Studies

Figure 17. Ankylosing Spondylitis Case Studies

Figure 18. Fibromyalgia Case Studies

Figure 19. Others Case Studies

Figure 20. Arthritis Monoclonal Antibodies Report Years Considered

Figure 21. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 22. Global Arthritis Monoclonal Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 23. Global Arthritis Monoclonal Antibodies Market Share by Region: 2024 VS 2031

Figure 24. Global Arthritis Monoclonal Antibodies Market Share by Players in 2024

Figure 25. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Monoclonal Antibodies as of 2024)

Figure 26. The Top 10 and 5 Players Market Share by Arthritis Monoclonal Antibodies Revenue in 2024

Figure 27. North America Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. North America Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 29. United States Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Canada Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Europe Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 33. Germany Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. France Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. U.K. Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Italy Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Russia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Nordic Countries Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Region (2020-2031)

Figure 41. China Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Japan Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. South Korea Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. India Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Australia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Latin America Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 49. Mexico Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Brazil Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Country (2020-2031)

Figure 53. Turkey Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. UAE Arthritis Monoclonal Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. AbbVie Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 57. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 58. Novartis Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 59. Johnson & Johnson(Janssen) Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 60. Pfizer Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 61. Mylan Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 62. Genentech Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 63. GSK Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 64. AstraZeneca PLC Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024

Global Therapeutic Monoclonal Antibodies Drug Market Research Report 2024

Global Anti TNF α Monoclonal Antibody Market Insights Forecast to 2030

Global Monoclonal Antibodies Product Market Research Report 2024

Global Anti CD25 Monoclonal Antibody Market Research Report 2024

Global Monoclonal Antibodies for Alzheimer Disease Market Research Report 2024

Global Lipopolysaccharides Monoclonal Antibody Market Research Report 2024

Global Anti CD20 Monoclonal Antibodies Market Research Report 2024

Global Aβ Monoclonal Antibody Drug Market Research Report 2024

Global Monoclonal Antibodies In Veterinary Health Market Research Report 2025

Global Long Acting Monoclonal Antibodies Market Research Report 2024

Monoclonal Antibody Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Monoclonal Antibody Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biologics Monoclonal Antibodies Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Next Generation Monoclonal Antibodies Market Research Report 2024

Global Myoglobin Monoclonal Antibody Market Research Report 2024

Global IL 17 Monoclonal Antibody Injections Market Research Report 2024

Global Research Area Antibodies Market Research Report 2025

Global Ubiquitin Monoclonal Antibody Market Research Report 2024

RELATED REPORTS

Global Osteoarthritis Pain Solution Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20Y6853

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Regenerative Therapies for Osteoarthritis Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36Y13907

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Rheumatoid Arthritis Diagnosis Tests Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19O6132

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Psoriatic Arthritis Therapeutics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9A6304

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions